Marker Therapeutics | 3: Initial statement of beneficial ownership of securities-Officer Lurier Eliot M
Jul 5, 2023 16:22 ET
Marker Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Eansor Norman David
Jun 8, 2023 21:35 ET
Marker Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Knobil Katharine
Jun 8, 2023 21:34 ET
Marker Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Wilson John Robert
Jun 8, 2023 21:33 ET
Marker Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director ELMS STEVE
Jun 8, 2023 21:32 ET
Marker Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Vera Juan
May 11, 2023 18:10 ET
Marker Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals(Amendment)-Aisling Capital IV, LP(5.46%),Steve Elms(5.46%), etc.
Mar 3, 2023 16:30 ET
Marker Therapeutics | 4: Statement of changes in beneficial ownership of securities
Mar 1, 2023 16:52 ET
Marker Therapeutics | 4: Statement of changes in beneficial ownership of securities
Mar 1, 2023 16:51 ET
Marker Therapeutics | 4: Statement of changes in beneficial ownership of securities
Mar 1, 2023 16:50 ET
Marker Therapeutics | 4: Statement of changes in beneficial ownership of securities
Mar 1, 2023 16:49 ET
Marker Therapeutics | 4: Statement of changes in beneficial ownership of securities
Mar 1, 2023 16:48 ET
Marker Therapeutics | 4: Statement of changes in beneficial ownership of securities
Mar 1, 2023 16:47 ET
Marker Therapeutics | 4: Statement of changes in beneficial ownership of securities
May 26, 2022 16:12 ET
Marker Therapeutics | 4: Statement of changes in beneficial ownership of securities
May 26, 2022 16:10 ET
Marker Therapeutics | 4: Statement of changes in beneficial ownership of securities
May 26, 2022 16:10 ET
Marker Therapeutics | 4: Statement of changes in beneficial ownership of securities
May 26, 2022 16:09 ET
Marker Therapeutics | 4: Statement of changes in beneficial ownership of securities
May 26, 2022 16:08 ET
Marker Therapeutics | 4: Statement of changes in beneficial ownership of securities
Mar 28, 2022 21:06 ET
Marker Therapeutics | 4: Statement of changes in beneficial ownership of securities
Mar 28, 2022 21:04 ET
No Data
No Data